Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.17 HKD
Change Today +0.004 / 2.44%
Volume 8.5M
8085 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 10:41 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

hong kong life sciences (8085) Snapshot

Open
$0.17
Previous Close
$0.16
Day High
$0.17
Day Low
$0.16
52 Week High
06/30/15 - $0.28
52 Week Low
08/25/15 - $0.13
Market Cap
663.7M
Average Volume 10 Days
14.8M
EPS TTM
$-0.02
Shares Outstanding
4.0B
EX-Date
07/4/05
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HONG KONG LIFE SCIENCES (8085)

Related News

No related news articles were found.

hong kong life sciences (8085) Related Businessweek News

No Related Businessweek News Found

hong kong life sciences (8085) Details

Hong Kong Life Sciences and Technologies Group Limited, an investment holding company, operates in the anti-aging and stem cell technology, trading, and money lending businesses in the People’s Republic of China and Hong Kong. The company offers stem cell storage and processing, anti-aging and beauty, and stem cell anti-aging application related services. It is also involved in the distribution of biomedical and life sciences products; provision of secured and unsecured loans for individuals and corporations, as well as security investment services; and investment and management of hotels. The company was formerly known as ZMAY Holdings Limited and changed its name to Hong Kong Life Sciences and Technologies Group Limited in October 2012. Hong Kong Life Sciences and Technologies Group Limited was incorporated in 2000 and is headquartered in Central, Hong Kong.

146 Employees
Last Reported Date: 06/24/15
Founded in 2000

hong kong life sciences (8085) Top Compensated Officers

Executive Director and Member of Remuneration...
Total Annual Compensation: $640.0K
Compensation as of Fiscal Year 2015.

hong kong life sciences (8085) Key Developments

Hong Kong Life Sciences and Technologies Group Limited Announces Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2015

Hong Kong Life Sciences and Technologies Group Limited announced unaudited consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported turnover of HKD 7,270,000 compared to HKD 236,737,000 a year ago. Profit before tax was HKD 2,304,000 compared to loss of HKD 25,151,000 a year ago. Loss for the period from continuing operations was HKD 1,122,000 or 0.01 cents per basic and diluted share compared to HKD 25,151,000 or 0.58 cents per basic and diluted share a year ago. Loss for the period attributable to owners of the company was HKD 6,149,000 or 0.16 cents per basic and diluted share compared to HKD 24,659,000 or 0.62 cents per basic and diluted share a year ago.

Hong Kong Life Sciences and Technologies Group Limited Announces the Resignation of Lu Zhiqiang as Non-Executive Director

Hong Kong Life Sciences and Technologies Group Limited announced that Mr. Lu Zhiqiang has resigned as a non-executive director with effect from July 9, 2015.

Hong Kong Life Sciences and Technologies Group Limited Announces Board Changes

The Board of Hong Kong Life Sciences and Technologies Group Limited announced that Mr. Chi Chi Hung, Kenneth did not offer himself for re-election as Director due to his intention to concentrate on his own business engagement and therefore he retired as an independent non-executive Director and ceased to be the chairman of each of the audit committee, remuneration committee and nomination committee upon conclusion of the AGM. Mr. Chi confirmed that he has no disagreement with the Board and there are no any matters relating to his retirement that needs to be brought to the attention of the shareholders. Furthermore, following the retirement of Mr. Chi and upon conclusion of the AGM, Mr. Hung Yat Ming, an independent non-executive Director, has been appointed as the chairman of each of the audit committee, remuneration committee and nomination committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8085:HK $0.17 HKD +0.004

8085 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8085.
View Industry Companies
 

Industry Analysis

8085

Industry Average

Valuation 8085 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.5x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HONG KONG LIFE SCIENCES, please visit www.hklifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.